Phase 3 trial of buntanetap for early-sta... - Cure Parkinson's

Cure Parkinson's

26,569 members27,876 posts

Phase 3 trial of buntanetap for early-stage Parkinson’s nears end

Veravrida profile image
5 Replies

Phase 3 trial of buntanetap for early-stage Parkinson’s nears end – The last patient completed the final visit in a Phase 3 trial testing buntanetap in people with early-stage Parkinson’s disease.

Read more at parkinsonsnewstoday.com/new...

Are there participants in this group who took part in this trial and would like to share their experience.

Written by
Veravrida profile image
Veravrida
To view profiles and participate in discussions please or .
5 Replies
jimcaster profile image
jimcaster

I participated in the trial. I may have been given a placebo, but I didn't experience any noticeable benefit. I don't think six months is long enough to determine efficacy. It may have slowed or stopped progression, but the disease progresses so slowly that it's impossible to know.

BPW1 profile image
BPW1 in reply tojimcaster

I was also in the trial and noticed no changes over the 6 months.

Ed-shakes profile image
Ed-shakes in reply toBPW1

But did your symptoms got worse?

power2k profile image
power2k in reply toEd-shakes

Same question: did your symptoms get worse, or in other words, did your disease conditions progress after 6 months in the trial? If your conditions get stabilized or your progress slows down, then the drug still works imo.

BPW1 profile image
BPW1 in reply topower2k

My symptoms stayed the same but I started exercising religiously and got my diet in check. Strength training, five days a week and do cardio 4 to 5 times a week along with agility training. I’ve been off the drug since September 1 and my symptoms haven’t gotten worse since I’ve been off it. So I’m not sure if it was the drug or just me taking care of myself.

Not what you're looking for?

You may also like...

ANNOVIS BIO ANNOUNCES POSITIVE FDA FEEDBACK FOR BUNTANETAP PHASE 3 CLINICAL DEVELOPMENT IN PARKINSON'S DISEASE (ANVS401)

https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?releaseID=111474&d=20

Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease

Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s...

Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease

This trial is already open in the United States, and I believe some on this forum are...
Canddy profile image

Annovis Bio have published the results of their dose-finding, biomarker study of buntanetap in 14 early Alzheimers & 14 Parkinsons patients

have published the results of their dose-finding, biomarker study of buntanetap (known as Posiphen...

MRI-Focused Ultrasound Undergoing Phase 3 Clinical Trial for Parkinson’s Treatment

New technology that uses MRI-guided focused ultrasound to target areas of the brain affected by...
Farooqji profile image